Dosage typically ranges from 200400mcg per administration
Tekturna [package insert]
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
In brief: wipe both vial tops with alcohol, draw the specified diluent volume using sterile equipment, inject it slowly down the inside wall of the product vial if instructed, then follow the pharmacy mixing instructions, such as gently swirling if allowed, until the product reaches the labelled expected appearance